ACE2 and COVID-19: In addition to the small prevalence of comorbidities, other mechanisms may explain differences in severity and incidence of COVID-19 in children compared to adults, such as angiotensin-converting enzyme-2 (ACE2) expression, efficient innate immune response, trained immunity and less lymphoid depletion (5, 8).